Health Economics Assessment of Rilpivirine Versus Comparators as First-Line Antiretroviral Therapies in HIV-1 Patients with a Viral Load (VL) ≤100,000 Copies/mL in France
Abstract
Authors
M. Cognet S. Druais R. Lahoulou D. Havet P. Guillon